Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surger...
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
About this item
Full title
Author / Creator
Schettino, Clorinda , Musacchio, Lucia , Bartoletti, Michele , Chiodini, Paolo , Arenare, Laura , Baldassarre, Gustavo , Califano, Daniela , Capoluongo, Ettore , Costi, Maria Paola , D'Incalci, Maurizio , Marchini, Sergio , Mezzanzanica, Delia , Normanno, Nicola , Scala, Stefania , Greggi, Stefano , Perrone, Francesco and Pignata, Sandro
Publisher
United States: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundPoly (ADP-ribose) polymerase inhibitors have transformed the management landscape for patients with ovarian cancer, demonstrating remarkable improvements in progression-free survival and overall survival. Unfortunately, most relapses are due to an acquired mechanism of resistance to these agents. We hypothesize that secondary cytoreductiv...
Alternative Titles
Full title
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
Authors, Artists and Contributors
Author / Creator
Musacchio, Lucia
Bartoletti, Michele
Chiodini, Paolo
Arenare, Laura
Baldassarre, Gustavo
Califano, Daniela
Capoluongo, Ettore
Costi, Maria Paola
D'Incalci, Maurizio
Marchini, Sergio
Mezzanzanica, Delia
Normanno, Nicola
Scala, Stefania
Greggi, Stefano
Perrone, Francesco
Pignata, Sandro
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2642324843
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2642324843
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-003435
